Serum gangliosides in mice with metastatic and non-metastatic brain tumors.
The content of serum gangliosides was examined in VM and C57BL/6J (B6) mice that contained subcutaneous metastatic (VM) and non-metastatic (CT-2A) brain tumors, respectively. Gas-liquid chromatography (GLC) and high performance thin-layer chromatography (HPTLC) were used to analyze the serum ganglio...
Main Authors: | M Cotterchio, T N Seyfried |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1994-01-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520401154 |
Similar Items
-
Influence of ganglioside GM3 and high density lipoprotein on the cohesion of mouse brain tumor cells.
by: H Bai, et al.
Published: (1997-01-01) -
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
by: Baek, R, et al.
Published: (2008) -
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
by: Baek, R, et al.
Published: (2004) -
Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice
by: Baek, R, et al.
Published: (2005) -
Metastatic Brain Tumors
by: Ersin Haciyakupoglu, et al.
Published: (2014-04-01)